Answers are grounded in this paper and cite their sources.
PREMISES: Patients with migraine have a co-morbidity with vascular diseases such as hypertension, coronary heart disease, and stroke. PROBLEM: This overview gives recommendations for the therapy of acute migraine attacks and for migraine prevention in patients with vascular diseases. In particular, the use of triptans in patients with vascular diseases is discussed. POTENTIAL SOLUTIONS: Currently, there is a contraindication for the use of the triptans in patients with vascular disease, although there is no evidence that triptans increase the risk of heart attacks or stroke.
No takes yet. Share an insight, caveat, or question.
Hans‐Christoph Diener (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: